
Opal Therapeutics
Opal Therapeutics is a femtech company in San Francisco, United States, founded in 2024. It has raised $275K across 1 round, most recently a $275K Grant in September 2024.
Catalyzing drug discovery for women's health in endometriosis and fibroids
- Headquarters
- San Francisco, California
- Employees
- 1–10
- Founded
- 2024
- Business Model
- B2B
- Website
- opaltherapeutics.com
- Total Funding
- $275K
- Last Round
- $275K GrantSep 2024
- Rounds
- 1
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 1 funding round and 1 investor for this company. The full record is or through the API.
About
Opal Therapeutics is a women's health biotech company building high-fidelity, patient-derived uterine organoid models of endometriosis and fibroids. Their platform helps biotech and pharma companies accelerate drug discovery and de-risk development through compound screening and biomarker validation using human preclinical data.
Summary
It lists 1–10 employees. It has raised $275K in total across 1 round, most recently a $275K Grant round in Sep 2024. Investors include National Science Foundation.
Funding History
Sep 2024
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...

Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/opal-therapeutics"><img src="https://indexed.vc/api/badge/company/opal-therapeutics" alt="Opal Therapeutics on Indexed.vc" width="260" height="76" /></a>